Jin Medical names Ning Xue independent director, replacing Jiayuan Tong

• Jin Medical International reported the resignation of independent director Jiayuan (James) Tong, effective July 9, 2026.
• Tong also stepped down as chair of the nominating and corporate governance committee, citing no dispute with the company.
• Ning Xue was appointed independent director effective July 14, 2026, filling the vacancy.
• Xue, founder and CEO of Beijing Taijibao Technology since 2016, previously led Beijing Ronzhiyun Culture and ran Shitong United Trading.
• Xue will chair the nominating and corporate governance committee, joining the audit and compensation committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-078342), on July 15, 2026, and is solely responsible for the information contained therein.